,
your personalized virtual assistant to find clinical trials. Go head, 
O. George Negrea, MD
Nancy N. and J. C. ...Savannah, Georgia - 31405 (312-864-5204) |
- CLINICAL TRIALS 5
- CONDITIONS15
- INTERVENTIONS18
- SINCE2003
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Daunorubicin Cytarabine and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
April 2008 - July 2013
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
October 2003 - January 2016
Breast Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Leukemia
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Carcinoma
Carcinoma, Non-Small-Cell Lung
Infertility
Neuroendocrine Tumors
Ovarian Failure, Premature
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Carcinoma, Neuroendocrine
Placebo
Rituximab
Filgrastim
Paclitaxel
Carboplatin
Bevacizumab
Cyclophosphamide
Prednisone
Cytarabine
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Goserelin
Daunorubicin Hydrochloride
Midostaurin
Cetuximab
Recombinant Interferon Alfa-2b
Octreotide Acetate
